VCEL Vericel Corporation

3.93
+0.07  (2%)
Previous Close 3.85
Open 3.85
Price To book 8.18
Market Cap 137013072
Shares 34,907,789
Volume 58,152
Short Ratio 1.26
Av. Daily Volume 764,180

SEC filingsSee all SEC filings

  1. CT ORDER - Confidential treatment order 171201048
  2. 10-Q - Quarterly report [Sections 13 or 15(d)] 171181291
  3. 8-K - Current report 171181129
  4. 8-K - Current report 171092059
  5. SC 13G - Statement of acquisition of beneficial ownership by individuals 171053900

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2b topline data released March 2016. Full data released April 2016
ixmyelocel-T
Stem cells - Dilated Cardiomyopathy
FDA Approval announced December 13, 2016 ahead of PDUFA date of January 3 2017.
MACI
Focal chondral cartilage defects in the knee.

SEC Filings

  1. CT ORDER - Confidential treatment order 171201048
  2. 10-Q - Quarterly report [Sections 13 or 15(d)] 171181291
  3. 8-K - Current report 171181129
  4. 8-K - Current report 171092059
  5. SC 13G - Statement of acquisition of beneficial ownership by individuals 171053900
  6. CT ORDER - Confidential treatment order 171028303
  7. 8-K/A [Amend] - Current report 171021698
  8. CT ORDER - Confidential treatment order 171020212
  9. 10-Q - Quarterly report [Sections 13 or 15(d)] 171017376
  10. 8-K/A [Amend] - Current report 171017250